RAVI GHANTA to Patient Readmission
This is a "connection" page, showing publications RAVI GHANTA has written about Patient Readmission.
Connection Strength
2.443
-
Safety of Early Discharge After Coronary Artery Bypass Grafting: A Nationwide Readmissions Analysis. Ann Thorac Surg. 2024 09; 118(3):701-710.
Score: 0.635
-
Development of a Risk Score to Predict 90-Day Readmission After Coronary Artery Bypass Graft. Ann Thorac Surg. 2021 02; 111(2):488-494.
Score: 0.481
-
Incidence, Cost, and Risk Factors for Readmission After Coronary Artery Bypass Grafting. Ann Thorac Surg. 2019 06; 107(6):1782-1789.
Score: 0.433
-
Low socioeconomic status adversely influences outcomes after coronary artery bypass grafting. J Thorac Cardiovasc Surg. 2025 11; 170(5):1480-1490.e5.
Score: 0.165
-
Readmissions After Surgical Aortic Valve Replacement: Influence of Prosthesis Type. J Surg Res. 2023 07; 287:124-133.
Score: 0.145
-
Readmission After Bioprosthetic vs Mechanical Mitral Valve Replacement in the United States. Ann Thorac Surg. 2024 01; 117(1):113-118.
Score: 0.138
-
Outcomes, Cost, and Readmission After Surgical Aortic or Mitral Valve Replacement at Safety-Net and Non-Safety-Net Hospitals. Ann Thorac Surg. 2022 09; 114(3):703-709.
Score: 0.135
-
Machine Learning to Predict Outcomes and Cost by Phase of Care After Coronary Artery Bypass Grafting. Ann Thorac Surg. 2022 09; 114(3):711-719.
Score: 0.131
-
Ninety-Day Readmission After Open Surgical Repair of Stanford Type A Aortic Dissection. Ann Thorac Surg. 2022 06; 113(6):1971-1978.
Score: 0.130
-
A Prospective Multi-Institutional Cohort Study of Mediastinal Infections After Cardiac Operations. Ann Thorac Surg. 2018 Feb; 105(2):461-468.
Score: 0.025
-
A multi-institutional cohort study confirming the risks of Clostridium difficile infection associated with prolonged antibiotic prophylaxis. J Thorac Cardiovasc Surg. 2018 02; 155(2):670-678.e1.
Score: 0.025